Directly disrupting the Keap1-Nrf2 complex can activate the protein levels of Nrf2 and thereby provide a cell protection mechanism against oxidative assault when endogenous stress defence mechanisms are imbalanced, which could be part of critical therapies for kidney diseases. Here, KEAP1 is linked to kidney disorder.